Another finding of present study was that MAP2K1 methylation was significantly different both in AD and MCI, and it was differentially expressed in multiple regions of the brain in AD, including Entorhinal Cortex, Temporal Cortex, Hippocampus and Frontal Cortex. This evidence concerns the gene MAP2K1 and Alzheimer disease.